In the third part of this series the net continues to be spread a little wider to include conversations about biosampling, the IMAXT project, the company Cyted, personalised radiotherapy and much, much more. As always you will hear discussions about research and research collaborations, the techniques that are being developed and how they translate to the clinic to affect patient treatments and outcomes.
In the first episode of part three, podcast host Ellie Wolmark is joined by Professor Robert Rintoul and Lauren Wallis to talk about biological sampling. They discuss what biosamples and biobanks are, how they are collected and used, and why they are so important for both patient treatment and cancer research.
Robert Rintoul is Professor of Thoracic Oncology in the Department of Oncology at the University of Cambridge and Honorary Consultant Respiratory Physician at Royal Papworth Hospital.
Lauren Wallis is Translational Research Manager in the Urological Malignancies Programme at the University of Cambridge.
